174 related articles for article (PubMed ID: 32849555)
21. Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease.
Szczepański T; Beishuizen A; Pongers-Willemse MJ; Hählen K; Van Wering ER; Wijkhuijs AJ; Tibbe GJ; De Bruijn MA; Van Dongen JJ
Leukemia; 1999 Feb; 13(2):196-205. PubMed ID: 10025893
[TBL] [Abstract][Full Text] [Related]
22. [Gene rearrangement pattern of immunoglobulin and T-cell receptor (Ig/TR) and its clinical characteristics in children with SET-NUP214 fusion gene-positive leukemia/lymphoma].
Li WJ; Cui L; Gao C; Zhao XX; Liu SG; Xin YP; Zhang RD; Zhang DW; Wang B; Li ZG; Wu MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1362-7. PubMed ID: 22169284
[TBL] [Abstract][Full Text] [Related]
23. Validation of a Combined Transcriptome and T Cell Receptor Alpha/Beta (TRA/TRB) Repertoire Assay at the Single Cell Level for Paucicellular Samples.
Litjens NHR; Langerak AW; van der List ACJ; Klepper M; de Bie M; Azmani Z; den Dekker AT; Brouwer RWW; Betjes MGH; Van IJcken WFJ
Front Immunol; 2020; 11():1999. PubMed ID: 33013853
[TBL] [Abstract][Full Text] [Related]
24. Digital Multiplex Ligation-Dependent Probe Amplification for Detection of Key Copy Number Alterations in T- and B-Cell Lymphoblastic Leukemia.
Benard-Slagter A; Zondervan I; de Groot K; Ghazavi F; Sarhadi V; Van Vlierberghe P; De Moerloose B; Schwab C; Vettenranta K; Harrison CJ; Knuutila S; Schouten J; Lammens T; Savola S
J Mol Diagn; 2017 Sep; 19(5):659-672. PubMed ID: 28736295
[TBL] [Abstract][Full Text] [Related]
25. Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia.
Brüggemann M; van der Velden VH; Raff T; Droese J; Ritgen M; Pott C; Wijkhuijs AJ; Gökbuget N; Hoelzer D; van Wering ER; van Dongen JJ; Kneba M
Leukemia; 2004 Apr; 18(4):709-19. PubMed ID: 14961040
[TBL] [Abstract][Full Text] [Related]
26. T-cell receptor alpha and delta gene assembly in B-cell precursor acute lymphoblastic leukemia.
Hara J; Kawa-Ha K
Leuk Lymphoma; 1992 Aug; 7(5-6):363-70. PubMed ID: 1493438
[TBL] [Abstract][Full Text] [Related]
27. Uses of polymerase chain reaction in leukemia: detection of minimal residual disease and identification of novel genetic mutations.
Lee MS; Stass SA
Cancer Treat Res; 1993; 64():35-44. PubMed ID: 8095797
[No Abstract] [Full Text] [Related]
28. Detection of clonal immunoglobulin and T-cell receptor gene rearrangements in childhood acute lymphoblastic leukemia using a low-cost PCR strategy.
Assumpção JG; Ganazza MA; de Araújo M; Silva AS; Scrideli CA; Brandalise SR; Yunes JA
Pediatr Blood Cancer; 2010 Dec; 55(7):1278-86. PubMed ID: 20730889
[TBL] [Abstract][Full Text] [Related]
29. [Detection of minimal residual disease in childhood acute lymphoblastic leukemia by using real-time quantitative PCR].
Zhang YT; Luo ZF; Fang JP; Guo HX; Huang K; Li CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1235-9. PubMed ID: 21129267
[TBL] [Abstract][Full Text] [Related]
30. Detection of ETV6 gene rearrangements in adult acute lymphoblastic leukemia.
Zhou MH; Gao L; Jing Y; Xu YY; Ding Y; Wang N; Wang W; Li MY; Han XP; Sun JZ; Wang LL; Yu L
Ann Hematol; 2012 Aug; 91(8):1235-43. PubMed ID: 22373549
[TBL] [Abstract][Full Text] [Related]
31. Deep targeted sequencing reveals the diversity of TRB-CDR3 repertoire in patients with preeclampsia.
Guo C; Cai R; Cao X; Yang Y; Wang Q; He R; An L; Peng Z; Chen Y; Ni S; Tan X; Han J; Liu X; Lin L; Yu S; Wang X; Wang C; Ma X
Hum Immunol; 2019 Oct; 80(10):848-854. PubMed ID: 30965079
[TBL] [Abstract][Full Text] [Related]
32. Vdelta2-Jalpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells.
Szczepanski T; van der Velden VH; Hoogeveen PG; de Bie M; Jacobs DC; van Wering ER; van Dongen JJ
Blood; 2004 May; 103(10):3798-804. PubMed ID: 14656882
[TBL] [Abstract][Full Text] [Related]
33. BPX-501 T cells interfere with minimal residual disease evaluation of B-cell acute lymphoblastic leukemia.
Amro Elshoury ; Wallace PK; Borowitz MJ; Kader A; Choi C; Ho C; Balderman S; Ross M; Hahn T; O'Neill V; McCarthy PL; Chen GL
Bone Marrow Transplant; 2018 May; 53(5):651-653. PubMed ID: 29343836
[No Abstract] [Full Text] [Related]
34. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
[TBL] [Abstract][Full Text] [Related]
35. Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry.
Mejstríková E; Fronková E; Kalina T; Omelka M; Batinić D; Dubravcić K; Pospísilová K; Vásková M; Luria D; Cheng SH; Ng M; Leung Y; Kappelmayer J; Kiss F; Izraeli S; Stark B; Schrappe M; Trka J; Starý J; Hrusák O
Pediatr Blood Cancer; 2010 Jan; 54(1):62-70. PubMed ID: 19760767
[TBL] [Abstract][Full Text] [Related]
36. Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detection.
Baruchel A; Cayuela JM; MacIntyre E; Berger R; Sigaux F
Br J Haematol; 1995 May; 90(1):85-93. PubMed ID: 7786801
[TBL] [Abstract][Full Text] [Related]
37. CDR3 size analysis of T cell receptor V beta transcripts: follow-up study in a patient with T cell acute lymphoblastic leukemia.
Prevost-Blondel A; Ostankovitch M; Melle J; Pannetier C; Macintyre E; Dreyfus F; Guillet JG
Leukemia; 1995 Oct; 9(10):1711-7. PubMed ID: 7564515
[TBL] [Abstract][Full Text] [Related]
38. Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
Spinelli O; Peruta B; Tosi M; Guerini V; Salvi A; Zanotti MC; Oldani E; Grassi A; Intermesoli T; Micò C; Rossi G; Fabris P; Lambertenghi-Deliliers G; Angelucci E; Barbui T; Bassan R; Rambaldi A
Haematologica; 2007 May; 92(5):612-8. PubMed ID: 17488684
[TBL] [Abstract][Full Text] [Related]
39. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
Popov AM; Verzhbitskaia TIu; Tsaur GA; Shorikov EV; Savel'ev LI; Tsvirenko SV; Fechina LG
Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
[TBL] [Abstract][Full Text] [Related]
40. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes.
Pongers-Willemse MJ; Verhagen OJ; Tibbe GJ; Wijkhuijs AJ; de Haas V; Roovers E; van der Schoot CE; van Dongen JJ
Leukemia; 1998 Dec; 12(12):2006-14. PubMed ID: 9844931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
